TIMP2 and renal cell carcinoma: To further confirm the role of TIMP2 in RCC clinical samples, we detected its expression via immunohistochemistry (IHC) in 23 pairs of human clinical samples derived from ccRCC tumor tissues and adjacent normal tissues.